OLD Category: Oncology

The histone lysine methyltransferase KMT2D sustains a gene expression program that represses B cell lymphoma development

• Ortega-Molina A et al.,

A four gene signature predicts benefit from anthracyclines: evidence from the BR9601 and MA.5 clinical trials

• Spears M. et al.,

Approaches to isolation and molecular characterization of disseminated tumor cells

• Magbanua M.J.M. et al.,

Processing of voided urine for prostate cancer RNA biomarker analysis

• Quek S-I. et al.,

Cell of origin of transformed follicular lymphoma

• Kridel R. et al.,

Development and verification of the PAM50-based Prosigna breast cancer gene signature assay

• Wallden B. et al.,

Phase II Study of Bevacizumab, Temozolomide and Hypofractionated Stereotactic Radiotherapy for Newly Diagnosed Glioblastoma

• Omuro A. et al.,

Prognostic Fifteen-Gene Signature for Early Stage Pancreatic Ductal Adenocarcinoma

• Chen D.T. et al.,

Prognostic Significance of Diffuse Large B-Cell Lymphoma Cell of Origin Determined by Digital Gene Expression in Formalin-Fixed Paraffin-Embedded Tissue Biopsies

• Scott D.W. et al.,

Clinical and pathological features of Burkitt lymphoma showing expression of BCL2 – an analysis including gene expression in formalin-fixed paraffin-embedded tissue

• Masque-Solar N. et al.,

Targeting the mRNA-binding protein HuR impairs malignant characteristics of pancreatic ductal adenocarcinoma cells

• Jimbo M. et al.,

Robust gene expression and mutation analyses of RNA-sequencing of formalin-fixed diagnostic tumor samples

• Graw S. et al.,